Bright Peak Therapeutics

company

About

Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.

  • 11 - 50

Details

Last Funding Type
Series B
Last Funding Money Raised
$107M
Industries
Biotechnology,Life Science,Therapeutics
Founded date
Jan 1, 2017
Number Of Employee
11 - 50
Operating Status
Active

Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases. At Bright Peak, they are creating innovative cytokine therapeutics that are uniquely engineered to precisely control and expand desired biological properties.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$142M
Bright Peak Therapeutics has raised a total of $142M in funding over 2 rounds. Their latest funding was raised on Jun 10, 2021 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 10, 2021 Series B $107M 1 Detail
Jul 28, 2020 Series A $35M 1 Versant Ventures Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Bright Peak Therapeutics is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures Series B